| 1 |
35053532 | Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin. | 2022 Jan 12 |
1 |
| 2 |
34044759 | miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop. | 2021 May 27 |
2 |
| 3 |
29248726 | Integrative analysis of rewired central metabolism in temozolomide resistant cells. | 2018 Jan 8 |
1 |
| 4 |
27177180 | Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist. | 2017 Feb |
3 |
| 5 |
26428461 | A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation. | 2015 Nov 28 |
1 |